Double Medical

Double Medical Technology Inc. (大博医疗) stands as one of China’s largest orthopedic implant manufacturers, with product lines spanning trauma, spine, joint, sports medicine, neurosurgery, and dental implants. Listed on the Shenzhen Stock Exchange since 2017 (002901.SZ), the company has expanded into surgical robotics as a strategic complement to its established implant business.

Company Overview

Founded in 2004 and headquartered in Xiamen, Fujian Province, Double Medical has grown into a broad-portfolio medical device enterprise with over 4,800 employees. The company operates from a 400,000 square meter manufacturing campus and has earned recognition as a National Technology Innovation Demonstration Enterprise and National Intellectual Property Demonstration Enterprise.

Double Medical’s core business revolves around high-value orthopedic consumables. The company holds the top domestic market share in trauma implants among Chinese brands and maintains leading positions in spinal and joint replacement products. Its product portfolio includes intramedullary nails, locking plates, spinal fusion devices, hip and knee prostheses, and dental implant systems.

Core Products

Orthopedic Implants

The company’s primary revenue comes from four major orthopedic categories:

• Trauma Products: Intramedullary nails, hollow screws, locking plates, and external fixators
• Spine Products: Pedicle screw systems, interbody fusion cages, and artificial vertebrae
• Joint Products: Hip and knee joint prostheses with both cemented and biological options
• Sports Medicine: Anchor systems and arthroscopic instruments

Knee Joint Surgical Robot

Double Medical has developed an orthopedic surgical robot system focused on knee joint replacement procedures. The robot features:

• AI-powered preoperative planning developed in collaboration with Tencent
• Positioning accuracy within 1.5mm
• 5G remote surgery capability
• Integration with the company’s joint implant product line

The knee robot entered clinical application in Q2 2025, with validation completed at over 30 tertiary hospitals and more than 200 surgical cases performed.

Technology & Innovation

Double Medical maintains one of the largest R&D teams in China’s orthopedic device industry, with over 500 research personnel across centers in Shanghai, Wuhan, Xi’an, and Chengdu. The company has established academic partnerships with Sichuan University, Harbin Institute of Technology, Huazhong University of Science and Technology, and other leading institutions.

Research initiatives span multiple domains:

• Advanced biomaterials development
• 3D printing technology for customized implants
• Intelligent surgical tools including robotic systems
• Process engineering and manufacturing optimization

The company operates a postdoctoral research station at its Xiamen headquarters and co-founded the Xiamen Medical Device R&D and Testing Center as a public technology service platform.

Market Presence

Double Medical serves hospitals across all Chinese provinces through an established distribution network. Internationally, the company exports to approximately 60 countries including Australia, Russia, and Chile, building competitive advantages in overseas markets.

Following national volume-based procurement (VBP) policies affecting orthopedic implants since 2021, the company has maintained and expanded market share as the industry consolidated toward major players. The surgical robot program represents a strategic investment to strengthen customer relationships and drive implant sales through an integrated “equipment + consumables” model.

Key Milestones

• 2004: Company founded in Xiamen
• 2017: Listed on Shenzhen Stock Exchange (002901.SZ)
• 2022: Initiated major capital investment project for production expansion
• 2024: Manufacturing capacity expansion completed
• 2025: Knee joint surgical robot enters clinical application

Frequently Asked Questions

What products does Double Medical manufacture?

Double Medical produces orthopedic implants across trauma, spine, joint replacement, and sports medicine categories, as well as neurosurgical and dental implants. The company has also developed a knee joint surgical robot system.

Is Double Medical publicly traded?

Yes, Double Medical trades on the Shenzhen Stock Exchange under stock code 002901.SZ since its 2017 IPO.

What is Double Medical’s strategy for surgical robots?

Double Medical positions its surgical robot as a complementary tool to drive sales of orthopedic implants rather than as a standalone profit center. This follows the industry trend of bundling surgical equipment with consumable products.